Literature DB >> 6742080

Local ocular hypotensive effect of topically applied acetazolamide.

A J Flach, J S Peterson, K A Seligmann.   

Abstract

Acetazolamide's usefulness in the treatment of the glaucomas is limited by the systemic side effects that often accompany its oral administration, and topical administration was initially thought to have no effect upon the intraocular pressures of human and rabbit eyes. Recent studies, however, have shown the usefulness of water-loading tests for screening drugs with potential antiglaucomatous activity. We found evidence that topical acetazolamide has the ability to lessen the increase in intraocular pressure after water-loading in pigmented rabbits and correlated this observation with low levels (0.0 to 0.7 microgram/ml) of plasma acetazolamide. Further, a separate study showed that 10% topical acetazolamide can enhance the ocular hypotensive effects of systemically administered acetazolamide in normal pigmented rabbits, suggesting that topically applied acetazolamide can have a local effect on intraocular pressure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6742080     DOI: 10.1016/0002-9394(84)90190-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study.

Authors:  F P Gunning; E L Greve; A M Bron; J M Bosc; J G Royer; J L George; P Lesure; D Sirbat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-07       Impact factor: 3.117

2.  Effect of the application of acetazolamide soaked contact lenses on intraocular pressure of rabbits.

Authors:  A Temel; H Kazokoglu
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

3.  Subconjunctival suspension of RU486 lowers intraocular pressure in normal rabbits.

Authors:  S Tsukahara; T Sasaki; C I Phillips; S M Gore
Journal:  Br J Ophthalmol       Date:  1986-06       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.